Max Robotics — Global Service Robot Directory + US Certification

About

J. Casanova is a leading figure in urologic oncology, with a focused expertise in the surgical management of prostate cancer following novel focal therapies. His most impactful work centers on the intersection of minimally invasive interventions and radical surgery, specifically investigating the feasibility and outcomes of radical prostatectomy after vascular targeted photodynamic therapy (VTP) with padeliporfin. In his highly cited 2018 study, which has garnered 26 citations, Casanova provided critical evidence that radical prostatectomy remains a safe and effective salvage option after VTP, demonstrating acceptable functional and early oncologic results. This contribution is pivotal for clinicians navigating the evolving landscape of prostate cancer treatment, where focal therapies like VTP are increasingly used to reduce morbidity. By confirming that surgical pathways are not compromised, Casanova’s research helps expand treatment flexibility and patient counseling. His work underscores a commitment to optimizing multimodal care, ensuring that patients who undergo VTP retain viable surgical options. Casanova’s findings have informed clinical guidelines and sparked further investigation into long-term outcomes, solidifying his role as a key contributor to the advancement of prostate cancer management.